What's Tay-Sachs disease?
Tay-Sachs disease is an inherited condition caused by changes in the HEXA gene. That gene normally helps the body break down a fatty substance called GM2 ganglioside, so when it does not work the substance builds up and damages nerve cells.
| Also indexed as | OMIM:272800, MONDO:0010100 |
|---|---|
| Features mapped | 16 |
| Treatments mapped | 0 |
| Published sources | 8 |
| Last reviewed | 2026-08-04 |
Signs and symptoms
Blindness
Loss of vision develops as the disease advances, alongside seizures and increasing stiffness of the limbs.
GM2-ganglioside accumulation
Because the HEXA enzyme cannot break it down, GM2 ganglioside builds up inside nerve cells, which drives the damage seen in the disease.
Infantile onset
The classic and most common form of Tay-Sachs begins in infancy. Babies usually develop normally for the first few months, then stall and lose skills, with the disease following a rapid course in the first years of life.
Exaggerated startle response
An exaggerated startle response to sound, together with overactive reflexes, is a common early sign as the condition affects the nervous system.
Apathy
in the later-onset form of the disease, psychiatric symptoms can be a frequent and prominent part of the picture, which may include reduced motivation or emotional flatness (apathy).
Seizure
Seizures develop as the condition progresses and the nervous system is increasingly affected.
Dementia
in tay-sachs, a fatty substance called GM2 ganglioside builds up inside nerve cells of the brain and spinal cord because the enzyme that normally clears it is lacking. this progressive damage to brain cells underlies the loss of thinking and memory abilities.
Psychomotor deterioration
From around 3 to 6 months of age a baby with Tay-Sachs gradually loses motor skills and alertness they had gained, a steady decline over time.
Autosomal recessive inheritance
Tay-Sachs is passed on in an autosomal recessive pattern: a child develops it only when they inherit a changed copy of the gene from both parents.
Cherry red spot of the macula
A 'cherry-red spot' at the centre of the retina is a characteristic eye finding in Tay-Sachs and can be seen by a doctor looking into the eye.
Hypertonia
As Tay-Sachs advances, the early floppiness gives way to muscle stiffness and spasticity, with rigid limbs and exaggerated reflexes as the nervous system deteriorates.
Hypotonia
Early in infantile Tay-Sachs, babies often become unusually floppy with weak muscle tone (hypotonia), losing the strength and head control they had begun to develop. As the disease progresses this can later turn into stiffness.
Generalized hypotonia
low muscle tone throughout the body (hypotonia), felt as unusual floppiness, is one of the common early signs of infantile tay-sachs, alongside stalled development and an exaggerated startle.
Poor head control
as infantile tay-sachs progresses, babies lose motor skills they had gained; in one study every child who had learned to sit without support lost that ability within a year. weak head and trunk control are part of this loss.
Aspiration
as tay-sachs advances, swallowing becomes unsafe and food or liquid can enter the airway (aspiration). a feeding tube placed into the stomach was associated with longer survival in infantile disease.
Macrocephaly
Over time, the head in infantile Tay-Sachs grows abnormally large (macrocephaly). This happens because GM2 ganglioside builds up inside brain cells, swelling the brain rather than reflecting healthy growth.
How it is diagnosed
Tay-Sachs disease
Diagnosed using: hexosaminidase A enzyme assay.
“Diagnosis is based on enzymatic testing showing reduced or absent hexosaminidase A activity, confirmed by genetic testing.”
Tay-Sachs disease
Diagnosed using: HEXA genetic testing.
“We presented three Korean children, who were recently diagnosed with infantile-type TSDvia enzyme assay and genetic analysis.”
Tay-Sachs disease
Diagnosed using: genetic counseling and carrier testing.
“Prenatal diagnosis and genetic counseling play a key role in prevention and reproductive decision-making, especially in high-risk populations.”
Tay-Sachs disease
Diagnosed using: dilated fundus examination.
“Presence of cherry-red spots in the macula led to conduction of biochemical and genetic studies for TSD confirmation.”
Treatment and management
No disease-modifying treatment is established for this condition in the research mapped here. This is a stated, reviewed fact, not a missing piece of this guide.
That does not mean nothing can be done. Supportive and symptomatic care, managing specific symptoms and complications as they arise, can still matter a great deal. What is right for any individual is a conversation for their own care team.
How to read the evidence labels
Where this comes from
This guide is built from 8 published source(s). Every claim above links back to one of them. Click any source ID to read the original on PubMed.
Take it further
Printed, source-linked documents built from this condition's graph — ready to bring to an appointment or attach to a coverage request. Every claim carries its published source, the same as this guide.